A detailed history of Israel Englander (Millennium Management LLC) transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 2,414,121 shares of PACB stock, worth $4.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,414,121
Previous 103,500 2232.48%
Holding current value
$4.32 Million
Previous $1.02 Million 791.82%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$3.52 - $9.59 $8.5 Million - $23.2 Million
2,414,121 New
2,414,121 $9.05 Million
Q2 2023

Aug 14, 2023

BUY
$9.97 - $14.05 $13 Million - $18.3 Million
1,303,381 New
1,303,381 $17.3 Million
Q4 2022

Feb 14, 2023

BUY
$5.67 - $11.2 $1.92 Million - $3.79 Million
338,261 Added 129.29%
599,888 $4.91 Million
Q3 2022

Nov 14, 2022

BUY
$3.93 - $8.57 $761,075 - $1.66 Million
193,658 Added 284.92%
261,627 $1.52 Million
Q2 2022

Aug 15, 2022

SELL
$4.02 - $10.43 $9.52 Million - $24.7 Million
-2,368,933 Reduced 97.21%
67,969 $300,000
Q1 2022

May 16, 2022

BUY
$8.43 - $20.9 $16.7 Million - $41.4 Million
1,978,498 Added 431.61%
2,436,902 $22.2 Million
Q4 2021

Feb 14, 2022

BUY
$19.26 - $30.08 $1.33 Million - $2.08 Million
69,124 Added 17.76%
458,404 $9.38 Million
Q3 2021

Nov 15, 2021

SELL
$24.86 - $35.02 $6.9 Million - $9.73 Million
-277,725 Reduced 41.64%
389,280 $9.95 Million
Q2 2021

Aug 16, 2021

BUY
$22.3 - $36.02 $7.23 Million - $11.7 Million
324,372 Added 94.67%
667,005 $23.3 Million
Q1 2021

May 17, 2021

SELL
$26.38 - $51.15 $29.9 Million - $58 Million
-1,132,951 Reduced 76.78%
342,633 $11.4 Million
Q4 2020

Feb 16, 2021

SELL
$10.5 - $28.5 $7.22 Million - $19.6 Million
-687,281 Reduced 31.78%
1,475,584 $38.3 Million
Q3 2020

Nov 16, 2020

BUY
$3.61 - $9.87 $459,921 - $1.26 Million
127,402 Added 6.26%
2,162,865 $21.3 Million
Q2 2020

Aug 14, 2020

SELL
$2.65 - $4.03 $836,960 - $1.27 Million
-315,834 Reduced 13.43%
2,035,463 $7.02 Million
Q1 2020

May 14, 2020

SELL
$2.36 - $5.26 $446,731 - $995,681
-189,293 Reduced 7.45%
2,351,297 $7.2 Million
Q4 2019

Feb 14, 2020

BUY
$4.6 - $5.57 $3 Million - $3.63 Million
651,690 Added 34.5%
2,540,590 $13.1 Million
Q3 2019

Nov 14, 2019

BUY
$4.99 - $6.16 $6.18 Million - $7.63 Million
1,239,200 Added 190.73%
1,888,900 $9.75 Million
Q2 2019

Aug 15, 2019

SELL
$5.92 - $7.41 $12.3 Million - $15.4 Million
-2,080,762 Reduced 76.21%
649,700 $3.93 Million
Q1 2019

May 14, 2019

BUY
$6.8 - $7.4 $437,743 - $476,367
64,374 Added 2.41%
2,730,462 $19.7 Million
Q4 2018

Feb 14, 2019

BUY
$3.99 - $7.82 $9.35 Million - $18.3 Million
2,343,773 Added 727.17%
2,666,088 $19.7 Million
Q3 2018

Nov 14, 2018

SELL
$3.52 - $5.55 $77,014 - $121,428
-21,879 Reduced 6.36%
322,315 $1.74 Million
Q2 2018

Aug 14, 2018

BUY
$2.11 - $3.92 $115,355 - $214,310
54,671 Added 18.88%
344,194 $1.22 Million
Q1 2018

May 15, 2018

BUY
$2.05 - $3.23 $335,722 - $528,967
163,767 Added 130.23%
289,523 $594,000
Q4 2017

Feb 14, 2018

SELL
$2.59 - $5.44 $2.17 Million - $4.55 Million
-836,465 Reduced 86.93%
125,756 $332,000
Q3 2017

Nov 14, 2017

BUY
$3.2 - $5.57 $3.08 Million - $5.36 Million
962,221
962,221 $5.05 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $402M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.